SCHEMBL4020181

SCHEMBL4020181

CCCCCCCCC=CCCCCCCCCCCNC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 10/20 0.68
SLC6A5 Q9Y345 1/20 0.59
TERT O14746 3/20 0.58
MAPT P10636 2/20 0.58
BLM P54132 2/20 0.58
HSD17B10 Q99714 2/20 0.58
FABP4 P15090 2/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
POLB P06746 1/20 0.58
CYP2C9 P11712 1/20 0.58
ALOX15 P16050 1/20 0.58
APEX1 P27695 1/20 0.58
CYP2C19 P33261 1/20 0.58
RECQL P46063 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
DUSP3 P51452 1/20 0.58
MMP2 P08253 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023410 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL4021980 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL16465771 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL4023411 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL6869502 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL4021971 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL4020177 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL6869509 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL2067947 1.00 EPHX2 (0.68) EPHX2SLC6A5TERTMAPTBLM
SCHEMBL4017990 0.95 KDM4E (0.64) EPHX2HSD17B10FABP4LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476756-B2 Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2009-01-13 US disclosed
US-20080103197-A1 ALKYL-, ALKENYL- AND ALKYNYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI-AVENTIS (FR) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103197-A1 ALKYL-, ALKENYL- AND ALKYNYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS ALK, ALKBH3, IDH1 EPHX2 706/4885SLC6A5 3733/4885TERT 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.